Biosimilars Begin To 'Pay Off' For Biocon

 
• By Anju Ghangurde and Dean Rudge
  
ArrowSteps
Biosimilar launches have helped propel Biocon to record sales and profits growth • Source: Shutterstock

More from Strategy

More from Business